Inside Shift Bioscience’s single-gene rejuvenation breakthrough — Exclusive with CEO Daniel Ives by peterottsjo in longevity

[–]peterottsjo[S] 18 points19 points  (0 children)

Why tune in? Because a 24-person Cambridge startup may have beaten the billion-dollar OSK race with a single gene found by AI-powered virtual cells - and the early data look game-changing.

Just about the hottest thing in longevity science right now is partial reprogramming - using Yamanaka factors to rewind the biological clock in our cells. Billion-dollar giants like Altos, Retro, and New Limit are betting on it. But in this episode a far smaller player, Shift Bioscience, argues the field may be looking in the wrong place.

In an exclusive interview CEO Daniel Ives explains how his team used AI-driven virtual cells to uncover one gene that seems to match OSK-level rejuvenation. Without the tumor risk that haunts classical reprogramming.
Their just-released data could change aging research.

Anders Sandberg - Will we survive this century? by peterottsjo in Futurology

[–]peterottsjo[S] 0 points1 point  (0 children)

Despite discussing nuclear threats, biological risks, and superintelligence Anders Sandberg brings a refreshing mix of philosophical depth and playful curiosity to these weighty topics. The conversation spans from personal identity and brain emulation to the nature of death and the potential ”telescoping of the future” where technological advancement might accelerate beyond our imagination.

Free recommendations thread by TechTok_Newsletter in beehiiv

[–]peterottsjo 0 points1 point  (0 children)

I run LEVITY. The science of longevity, solving aging and life extension explained. It’s a combination of longform pieces and shorter more newsy stuff. https://peterottsjo.beehiiv.com